
Pfizer to earn $26bn, one third of sales, from vaccines in 2021
Pfizer Inc (PFE.N) on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to $26 billion and said demand from governments around the world fighting to ...